Pfizer backs down over ‘unreasonable’ terms in South Africa vaccine deal
19 Apr 2021 Pfizer has backed down over its controversial demand that the South African government put up sovereign assets guaranteeing an indemnity against the cost of any future legal cases, the Bureau of Investigative Journalism can reveal. ( Photo by Vincent Kalut / Photonews via Getty Images)
Pfizer has backed down over its controversial demand that the South African government put up sovereign assets guaranteeing an indemnity against the cost of any future legal cases, the Bureau of Investigative Journalism can reveal.
During Covid-19 vaccine negotiations, the company sought indemnity against civil claims from citizens who had experienced adverse vaccine effects meaning that the government would have to cover the costs instead.
Albania
South-africa
United-states
Peru
Dominican-republic
Kwazulu
Eastern-cape
Natal
South-african
American
Astrazeneca-oxford
Georg-neumann